Synthetic Biology Market Growth Forecast With Analysis Of Industry Progress Through 2030

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

By 2030, How Much Growth In Market Size Is Expected For The Synthetic Biology Market?

The synthetic biology market size has seen substantial growth in recent years. It is anticipated to expand from $26.63 billion in 2025 to $32 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 20.2%. The historical growth can be ascribed to advancements in genetic engineering techniques, the expansion of academic and industrial research funding, the increasing availability of sequencing technologies, the early commercialization of synthetic organisms, and growing collaboration between academia and industry.

The synthetic biology market is projected to experience substantial expansion over the forthcoming years. Its valuation is anticipated to reach $62.48 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 18.2%. This anticipated growth throughout the forecast period stems from several factors, including escalating investments in bio-manufacturing, a surging need for sustainable chemicals and fuels, the broadening scope of synthetic biology applications within healthcare, the increasing incorporation of AI-driven biological design, and improved regulatory clarity concerning engineered organisms. Key trends foreseen for this period encompass the growing acceptance of CRISPR-based gene editing, a greater utilization of bioinformatics-driven design tools, the enlargement of synthetic gene construction platforms, an intensified focus on sustainable bio-based production methods, and advancements in automation across biological engineering workflows.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2508&type=smp

What Important Drivers Are Powering The Synthetic Biology Market Growth?

Increased expenditure on research and development is anticipated to drive the expansion of the synthetic biology market in the future. Research and development (R&D) involves a systematic approach to investigation, experimentation, and innovation, leading to the generation of novel knowledge, technologies, or products, either to enhance current offerings or to formulate entirely new ones. Growth in research and development investments is attributed to heightened competition, the imperative for innovation, technological progress, and the necessity for enterprises to adjust to evolving consumer demands and market conditions. Funding for synthetic biology research and development is crucial for unlocking its potential to devise sustainable solutions across sectors like healthcare, agriculture, and environmental stewardship, achieved by engineering biological systems and organisms for predefined objectives. As an illustration, the Office for National Statistics, a UK government agency, reported that the UK government’s net expenditure on research and development (R&D) reached £17.4 ($22.1 billion) billion in 2023, an increase from £16.1 billion ($20.45 billion) in 2022, signifying an 8.2% surge. Consequently, the increased investment in research and development is fueling the expansion of the synthetic biology market.

What Key Segment Areas Are Included In The Synthetic Biology Market Assessment?

The synthetic biology market covered in this report is segmented –

1) By Technology: Nucleotide Synthesis And Sequencing, Bioinformatics, Microfluidics, Genetic Engineering

2) By Product Type: Oligonucleotides, Enzymes, Cloning And Assembly Kits, Xeno-Nucleic Acids (XNA), Chassis Organism

3) By Application: Pharmaceuticals And Diagnostics, Chemicals, Biofuels, Bioplastics, Other Application

Subsegments:

1) By Nucleotide Synthesis And Sequencing: DNA Synthesis Technologies, Next-Generation Sequencing (NGS), Sanger Sequencing

2) By Bioinformatics: Software Tools For Genomic Data Analysis, Databases For Gene/Protein Information, Algorithms For Gene Editing And Design

3) By Microfluidics: Lab-On-A-Chip Technologies, Microfluidic Devices For Biological Assays, Applications In Drug Discovery And Diagnostics

4) By Genetic Engineering: CRISPR/Cas9 Technology, Recombinant DNA Technology, Synthetic Gene Construction And Assembly

Which Trends Are Affecting The Synthetic Biology Market Framework?

Leading companies in the swine flu vaccination market are concentrating on developing innovative products, such as the quadrivalent influenza vaccine, to fortify their market position. A quadrivalent influenza vaccine is engineered to offer protection against four distinct influenza virus strains. For instance, in March 2024, Cadila Pharmaceuticals, an Indian-based pharmaceutical company, announced the launch of its advanced quadrivalent influenza vaccine, Cadiflu Tetra, specifically designed for influenza prevention. The Cadiflu Tetra Vaccine features a quadrivalent formulation that targets four influenza virus subtypes A and B strains. Its nano-sized particle technology replicates the virus’s external structure, increasing efficacy and safety while ensuring no intact genetic material is present. This sophisticated approach improves immunity against multiple influenza strains, providing a technologically superior option for averting seasonal epidemics.

Which Firms Are Competing In The Synthetic Biology Market?

Major companies operating in the synthetic biology market are Thermo Fisher Scientific Inc, Danaher Corporation, Eurofins Scientific, Merck KGaA, Novozymes A/S, Agilent Technologies, New England Biolabs Inc, Precigen Inc, Amyris, Inc, Genscript Biotech Corporation, Codex Genetics, Cathay Biotech, Bota Biosciences, Bluepha, Spiber, OriCiro Genomics Inc, Provectus Algae, Puraffinity, Royal DSM NV, Colorifix, Phytoform Labs, Desktop Genetics, NanoSyrinx, Pulmobiotics S.L, EnginZyme, Chain Biotech, Nuclera Nucleics, Biosynthetics GmbH, Entelechon GmbH, Sloning BioTechnology GmbH, Prokarium Ltd, Synbio, Captor Therapeutics, Gero.ai, ARNA Genomics, Solvo Omixon, Soft flow, Algenol, Genomatica, Integrated DNA Technologies, Sana Biotechnology, Impossible Foods, Apeel Sciences, Twist Bioscience, Synlogic, Zymergen Inc, Ginkgo Bioworks, Codexis, Arzeda Corporation, Synthetic Genomics, Conagen, Dupont, Oxitec Ltd, Sentebiolab, GEEN Biotechnology Inc, Genbiotek Biosistem Laboratory Ltd

Access The Complete Synthetic Biology Market Report:

https://www.thebusinessresearchcompany.com/report/synthetic-biology-global-market-report

Which Region Holds The Largest Share In The Synthetic Biology Market?

North America was the largest region in the synthetic biology market in 2025. Western Europe was the second largest region in the global synthetic biology market share. The regions covered in the synthetic biology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Synthetic Biology Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=2508&type=smp

Browse Through More Reports Similar to the Global Synthetic Biology Market 2026, By The Business Research Company

Synthetic Food Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/synthetic-food-global-market-report

Synthetic Hormones Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/synthetic-hormones-global-market-report

Computational Biology Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/computational-biology-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795